Pioneering a new approach to vaccine development and manufacturing using cutting-edge technologies to produce novel synthetic vaccines.
Emergex Vaccines has raised €9.9M across 1 funding round from 1 investor, most recently a Series A round in Sep 2020. Based in Abingdon, UK; founded 2016; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-09-01 | Series A |
| €9.9M |
| Vickers Venture Partners |
| View deal → |
